Dentists in Salisbury, NC Accepting Medicare
62 Dentists found. Showing 61 - 62
 Dr. James K Jolly, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1819 E Innes St, Salisbury, NC 28146 Phone: 704-633-7117 Fax: 704-633-4637 |
Dr. Ronald H Steelman, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1710 Walker Street, Salisbury, NC 28144 Phone: 704-636-5800 Fax: 704-636-5829 |
News Archive
Cryoablation increases survival rates in ovarian cancer patients
Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.
Worthington introduces new line of Animal/Xeno-Free products for biomedical research at EB 2015
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
New CWRU study identifies three glycosyltransferases as major mutational targets in colorectal cancer
Little is known about the molecular basis of aberrant protein glycosylation, a complex enzymatic process that is a hallmark of many human cancers including colorectal cancers (CRC), and how it may contribute to tumor progression. In a new study published in Scientific Reports, an online journal of the Nature Publishing Group, scientists at Case Western Reserve University School of Medicine have successfully characterized the mutational landscapes of glycosylation-associated genes in colon cancer, identifying three glycosyltransferases as significant mutational targets in CRC.
M-MDSCs may be effective in treating arthritis in humans
Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, might be an effective treatment for the disease in humans.
› Verified 8 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Psychologists
Occupational Therapists